Origin
YC W26San Francisco, US · Founded 2025 · 4 employees · 2 known investors
Origin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context. The platform combines spatial transcriptomics, imaging, and functional perturbation assays on fresh and archived tumors, paired with AI models for drug response prediction and target discovery.
Founders & leadership· Y Combinator alumni (W26)
Yash Rathodin𝕏Founder
Malhar Bhidein𝕏Founder
UM
Unnamed MIT ProfessorProfessor of Computer Science, MIT · Broad Institute
Fo
Founder of Siren BiotechnologyFounder & CEO, Siren Biotechnology · UCSF
Da
Dean at Grainger College of Engineering, UIUCDean, Grainger College of Engineering, UIUC
Investors · 2
In the news
- Jeff Bezos Put $2 Billion of His Own Money Into Blue Origin's Funding Round | The Motley Foolfool.com · 2026
- Kent-based Blue Origin seeks $10 billion in outside funding | Kent Reporterkentreporter.com · 2026
- Blue Origin seeks to raise $10 billion in outside capital - SpaceNewsspacenews.com · 2026
- Techbuzztechbuzz.ai · 2026
- Blue Origin raises $10B in first external funding round at $130B valuationproactiveinvestors.com · 2026
- Jeff Bezos’s Blue Origin Nears a Big Fund-Raising Round - The New York Timesnytimes.com · 2026